TABLE 4.
Relationship between clinicopathological characteristics and breast cancer patient DFS through Cox regression analysis based on TCGA.
| Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | |
| Age | 0.998 (0.981-1.015) | 0.780 | 0.995 (0.971-1.020) | 0.714 |
| Gender | 0.049 (0.000-339.148) | 0.504 | 0.000 (0.000-Inf) | 0.979 |
| Stage 2 | 1.498 (0.747-3.006) | 0.225 | 1.112 (0.441-2.803) | 0.822 |
| Stage 3 | 3.567 (1.735-7.333) | 0.001 | 2.868 (1.097-7.500) | 0.032 |
| Stage 4 | 13.733 (4.433-42.544) | <0.001 | 13.019 (3.204-52.894) | <0.001 |
| HER2+ | 2.752 (0.959-7.898) | 0.060 | 1.836 (0.551-6.121) | 0.323 |
| TNBC | 2.577 (1.344-4.943) | 0.004 | 2.802 (1.449-5.417) | 0.002 |
| FN1 | 1.324 (1.027-1.709) | 0.031 | 1.297 (0.890-1.890) | 0.175 |
Abbreviations: DFS, disease-free survival; HR, hazard ratio; 95% CI, 95% confidence interval.